# Efficacy of Stem Cell Therapy in Ambulatory and Non-ambulatory Children With Duchenne Muscular Dystrophy - Phase 1-2

> **NCT02484560** · PHASE1 · UNKNOWN · sponsor: **University of Gaziantep** · enrollment: 10 (actual)

## Conditions studied

- Duchenne Muscular Dystrophy

## Interventions

- **DRUG:** Biological: Umbilical Cord Based Allogenic Mesenchymal Stem Cell

## Key facts

- **NCT ID:** NCT02484560
- **Lead sponsor:** University of Gaziantep
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-06
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2015-07-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02484560

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02484560, "Efficacy of Stem Cell Therapy in Ambulatory and Non-ambulatory Children With Duchenne Muscular Dystrophy - Phase 1-2". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02484560. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
